Hybrid filler (hyaluronic acid and calcium hydroxylapatite)

Hybrid filler is a treatment using hyaluronic acid (HA) and calcium hydroxylapatite (CaHA) in a single product. The aim is volume support from the gel structure and stimulation of collagen production from the particulate component. The word hybrid describes the presence of these two components in the same preparation. A facial treatment area is selected according to skin thickness and support needs.

You may consult us about reduced cheek fullness, loss of support around the cheekbones, or a change in your jawline. During the examination, we explain where hybrid filler may be considered by distinguishing volume loss from skin laxity. We listen to the change you expect in the context of your whole face. This makes clear what volume support and collagen stimulation target in your plan.

Hyaluronic acid and calcium hydroxylapatite

Hyaluronic acid is a molecule also found in connective tissue that can retain water. Its form prepared for filler use is a gel that can create volume in tissue. Connections between molecules affect the gel’s consistency and physical behavior. These properties help determine the tissue layer and anatomical target for which the filler will be used.

In these products, calcium hydroxylapatite is present as small round particles called microspheres. The microspheres are dispersed within the gel. The response involving collagen production in the surrounding tissue is why this component is described as a biostimulator. Collagen is a structural protein that gives connective tissue strength; collagen stimulation describes the goal of encouraging tissue to produce this protein.

Hybrid fillers such as Harmonyca contain hyaluronic acid and calcium hydroxylapatite as components of the same product. Here, hybrid does not mean randomly mixing different fillers in the clinic. The product has a defined preparation and composition. Its possible treatment areas, injection layer, and ingredient suitability are determined from the preparation’s own properties.

The physical volume provided by the gel and the tissue’s collagen production response are different functions. Combining these functions in the same product does not mean the same use is suitable for every facial area. Skin thickness, underlying fat, and movement in the region influence selection. Whether the desired change relates to volume or skin structure should also be explained.

Differences from conventional fillers and biostimulators

Conventional hyaluronic acid filler is used to support or shape a selected area through gel volume. In a hybrid product, calcium hydroxylapatite microspheres accompany the hyaluronic acid gel. The material therefore cannot be treated as hyaluronic acid filler alone. The relationship between the particulate component and tissue is also considered when selecting the treatment area.

Biostimulator is a general term for substances intended to stimulate the tissue response involved in collagen production. PLLA (polylactic acid) and calcium hydroxylapatite belong to this group. Preparation methods and carriers may differ among these products. Hybrid filler has a defined combination of hyaluronic acid gel and calcium hydroxylapatite.

Hyperdilute calcium hydroxylapatite describes an approach in which the material is substantially diluted and distributed. This approach may target the skin’s supporting structure. A hybrid filler containing hyaluronic acid is a separate preparation with its own composition. A dilution technique and the name of a product class describe different things; how the proposed material is prepared is specified separately.

You may have heard the terms filler and biostimulator before the consultation. When explaining the product being considered, we describe your wish for cheekbone volume, the structure of your cheek skin, and the shape of your jawline separately. Each may not need to be targeted with the same material. Showing us the location of the change you want helps us explain the anatomical rationale for product selection through your own findings.

Can hybrid filler be dissolved?

Hyaluronidase is an enzyme that breaks down hyaluronic acid. It can act on the hyaluronic acid component of hybrid filler but does not dissolve calcium hydroxylapatite microspheres. The dissolving approach used for fillers containing only hyaluronic acid therefore cannot reverse the entire hybrid product.

The decision to use hybrid filler is made after this limit to reversal has been explained alongside the desired change. The treatment area and added volume are not selected on the assumption that they can later be fully reversed with an enzyme. During the consultation, you can explain how much dissolvability matters to you and ask whether a filler containing only hyaluronic acid would be suitable.

Midface and cheekbones

The midface includes the cheeks between the under-eye area and the area around the mouth. The cheekbone, fat compartments, and overlying skin shape this region. Prominence at the outer cheek and the transition extending under the eye do not depend on the same anatomical structure. The support area considered for hybrid filler is defined within these layers.

Volume loss may be localized around the cheekbone or spread across different parts of the cheek. Its distribution may differ between the right and left cheeks. Thin skin and reduced volume beneath it are also separate features. Filler planning considers tissue thickness on palpation as well as the face’s front and side views.

You can begin the examination by pointing to the cheek area you would like to change. A wish to emphasize the outer cheekbone contour and under-eye hollowness involve different treatment regions. We examine suitable overlying tissue and volume needs for hybrid filler with this distinction in mind. The transition between added volume in one part of the face and neighboring areas also remains part of the plan.

The line extending from the side of the nose to the corner of the mouth is called the nasolabial fold. Skin, cheek tissue position, and facial movement contribute to its appearance. It is not assumed that every visible line needs filler injected directly into it. Examining surrounding support and tissue movement helps identify the actual target area.

Jawline and skin laxity

The jawline is the outer contour along the edge of the lower jawbone. Bone shape, the chewing muscle, fat, and skin contribute to this contour’s appearance. Hybrid filler may be considered for tissue support in suitable areas. A hollow along the jaw edge and accumulated tissue next to it should not be treated as the same procedural target.

Skin laxity relates to the elasticity and supporting structure of the overlying tissue. Excess skin and displacement of underlying tissues may create other changes in the facial contour. Collagen stimulation does not surgically reposition these structures. Where there is pronounced sagging, a wish for added volume is examined separately from an approach to excess tissue.

When examining your jawline, we distinguish chin projection, the angle of the jaw, and lower facial volume distribution. You can describe the part of your side profile you would like to change. Excess tissue beneath the chin and a need for support along the jaw edge may not be addressed by adding filler to the same area. During the examination, we show which part is being considered for hybrid filler and which finding requires a different approach.

Limits in the lips and eye area

The lip is mobile tissue that continually changes shape during speech and smiling. Hybrid fillers containing hyaluronic acid and calcium hydroxylapatite are not suitable options for lip augmentation. The presence of hyaluronic acid does not mean that the product can replace a filler prepared for the lips. Its microspheres and the treatment area are considered together.

Thin skin around the eyes and lower eyelid tissue form a covering different from that of the cheek. These thin areas are not suitable sites for hybrid filler. Under-eye hollowness or darkness should be examined according to its own causes. A filler plan for the midface cannot be extended to include every area close to the eyelid.

A material’s suitability for use in the cheek does not mean it can also be used in areas such as the nose, forehead, or lips. Blood vessel arrangement, tissue movement, and overlying tissue thickness differ by region. The product’s areas of use are checked alongside this anatomy. Describing the whole face as a single filler area overlooks these distinctions.

Who is a candidate, and what is examined?

The position of the teeth and jawbones affects facial profile and support around the mouth. Hybrid filler treats soft tissue; it does not change the bite or bone position. If expectations for the jawline relate to the bite, this finding requires its own examination. Not every recessed feature in the profile is interpreted as a volume gap to be filled.

We also observe how your cheeks move when you smile and when your face is at rest. Changes in the shape of the area needing volume support during facial expressions affect our choice of material placement. During the consultation, you can describe the particular viewing angle from which you would like a change. Examining front and side views separately helps us distinguish cheekbone targets from jawline targets.

Hybrid filler may be considered for adults with goals involving volume support and skin structure in the cheeks or jawline. The skin’s ability to cover the material, the location of volume needs, and the scope of expectations all inform suitability. In an area with pronounced excess skin, adding volume alone may not match the desired change. This finding is explained separately during the examination.

Cosmetic hybrid filler treatments are postponed during pregnancy and breastfeeding. Injections are not performed in areas with an active infection. Known allergies to the product’s components also affect suitability. Other ingredients in the preparation, as well as its main substances, should be reviewed alongside the person’s medical and allergy history.

Uncontrolled systemic diseases, immune system diseases, and current treatments inform the decision to proceed. A keloid is raised tissue that extends beyond the boundaries of a skin scar. A history of such pronounced scarring is considered with collagen-stimulating products. The same decision is not applied to every diagnosis; the current condition and product’s instructions for use are the basis.

You can share records of previous fillers or operations. During the examination, we look at which material is present in which area, skin thickness, and tissue movement. The session plan is determined during the examination according to skin structure. We also record the distribution of volume needs on the right and left sides of the face and explain the area being considered for hybrid filler and the target layer.

Planning with other procedures

Botox is used to target the contraction of facial expression muscles. Hyaluronic acid skin boosters target hydration and surface quality, while polynucleotide treatments address skin structure using a different material. The volume support and collagen stimulation of hybrid filler are defined separately from these targets. How materials intended for the same area relate to one another and to existing tissue is also examined.

You can discuss forehead expression lines and a wish for cheek support in the same consultation. We explain which procedure targets which region and select the sequence according to skin findings and previous treatments. Considering hybrid filler for the cheek does not mean selecting the same material for the lips. If you would like added lip volume, we create a separate filler plan suited to that area’s movement.